KRN125 for Mobilization of Hematopoietic Stem Cells

NCT03993639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Blood Stem Cell Transplantation

Interventions

DRUG: Pegfilgrastim

Sponsor

Kyowa Kirin Co., Ltd.